Peregrine Ventures

SHAAR Healthcare Innovation Hub, we couldn’t agree more—Snipe Medical is setting a new standard in lung cancer treatment, and we are proud to have them in our portfolio!   Lung cancer remains the leading cause of cancer-related deaths worldwide, with over 2 million cases diagnosed annually. In the face of this global health challenge, Snipe Medical is leading the way with its minimally invasive Irreversible Electroporation (IRE) ablation device.   Snip's groundbreaking technology offers safer, less invasive treatments that reduce risks and recovery time for patients, provide a more effective tool compared to traditional therapies, and broaden access to impactful care worldwide. Thank you to SHAAR’s #MedTech program for providing support to this pioneering startup. Together, we are shaping a better future for patients worldwide.   #LungCancer #Innovation 

Last week, during the ICI Meeting December 9-10, 2024, we hosted our fourth annual cocktail gathering. This event has become a meaningful tradition for us, and while we planned for an intimate evening, the turnout exceeded all expectations. It was heartening to see so many colleagues and friends from across the #healthcare ecosystem come together, even in these challenging times. This year, more than ever, we were reminded of the strength and resilience of our community. We deeply appreciate everyone who joined us, fostering connection and dialogue as we continue working toward a common goal: to advance healthcare and improve lives for everyone, everywhere. Thank you for being part of this journey with us. Special thanks to Dana Bar Siman Tov for these amazing pictures! Eyal Lifschitz @Boaz Lifschitz Lior Shahory @Tamir Tal @Dudi Eldar Tal Carasso Shiran Tehila Mashiah Tamar Ben-Zvi Doron Levin Amit Talia Alfasi Ruben Schächter @Liat Gabay #LifeSciences #Innovation

We’re excited to participate in the International ICI Meeting December 9-10, 2024 in #TelAviv, a global flagship event for the #cardiovascular intervention ecosystem. Our Co-Founder and General Managing Partner, Eyal Lifschitz, will share his expertise in a talk on "Decrypting the Code: Building and Financing Successful Medical Device Companies in Tough Markets" during the Meet the VCs session on Monday, chaired by Dr. Irit Yaniv and Eran Lerer. On Monday, Lior Shahory, Peregrine’s General Partner and Incentive, Peregrine Ventures Incubator CEO, will serve as co-chairperson at the #Device #Innovation panel alongside Yuval Binur and Shmuel Banai. On Tuesday, our Co-Founder and General Managing Partner, Boaz Lifschitz, will co-chair the #Technology Parade Devices session together with Shimon Eckhouse and Shai Policker. As always, we’re proud to support our portfolio companies participating at the conference, who continue to drive #healthcare innovation. We look forward to connecting with global leaders, #entrepreneurs, and investors shaping the future of #medical technology. See you there!

Last week, we had the pleasure of hosting the Operations Division of the Israel Innovation Authority רשות החדשנות at our offices. During this visit, we presented a range of companies from our portfolio, showcasing startups at different stages of development—from early-stage incubator ventures to companies advancing through clinical trials and commercialization. The visit highlighted the strong collaboration between Peregrine and the Israel Innovation Authority. We deeply appreciate their professional support, commitment to streamlining support frameworks, and invaluable partnership that fuels #innovation and #growth. Thank you for your continued trust and collaboration! Together, we’re shaping the future of healthcare. #Healthcare #Startups #Israel

Proud to share that our portfolio company, Momentis Surgical™, has secured FDA clearance for its next-generation Anovo® robotic system – its second FDA approval in just two weeks! This advanced system brings capabilities previously unseen in #surgical #robotics, including haptic feedback, dual-mode articulation, and unmatched flexibility for both retroflexion and anteflexion within a single incision. These innovations empower physicians with enhanced usability, enabling robotic-assisted procedures that offer human-like dexterity, multi-planar flexibility, and 360-degree articulation. As the Anovo® console remains the only FDA-authorized surgical robotic system, featuring miniature humanoid-shaped robotic arms, Momentis is setting a new standard in robotic #surgery. We’re thrilled to see how Anovo® continues to revolutionize patient care worldwide! #MedicalInnovation, #RoboticSurgery, #HealthcareTech #VentureCapital #Israel

Thrilled to see Bio ReFine Ltd., our pioneering portfolio company in interventional cardiology, achieve this incredible breakthrough with a successful first-in-human use! The Coriofix system represents a leap forward for mitral valve repair, offering a unique implant-less annuloplasty solution. This innovative approach simplifies the procedure, enabling physicians to provide safer, fully endovascular treatments that improve patient outcomes in managing mitral regurgitation. If you’re attending #TCT2024, don’t miss the chance to connect and discover how BioRefine is reshaping the future of interventional structural cardiology. #InnovationInHealth #HeartValveRepair #MedTech

Thrilled to announce another milestone for Momentis Surgical™ , one of our pioneering #medical device portfolio companies, as they secure additional #FDA 510(k) clearance for their Anovo™ robotic platform—the world’s first single-port robotics system—now also approved for laparoscopic ventral hernia repairs. The platform enables surgeons to perform complex, minimally invasive procedures with the goal of enhancing patient outcomes and reducing healthcare costs. Frederic H. Moll, M.D., a Momentis board member and founder of Intuitive Surgical and Auris Health, shared, “This technology is clearly differentiating and will have an immediate impact on the way general surgery is performed.” What makes Anovo™ unique is its compact, mobile design, allowing it to be used in both hospitals and outpatient settings, including ambulatory surgical centers—making it more accessible than traditional robotic systems. Momentis began its journey in Peregrine’s Incentive, Peregrine Ventures Incubator in 2013, under the leadership of CEO Dvir Cohen. Peregrine’s Eyal Lifschitz, alongside the Peregrine team, has had the privilege of guiding and supporting Momentis through this incredible journey. We look forward to seeing the positive impact it will have on patients' lives. #Health #Innovation #medtech #medicaldevices https://lnkd.in/dc4crv9G

Last week, we had the privilege of participating in the #Innovation_Managers_Forum at Ichilov Tech. It was an insightful session with Dr. Gilad Lehmann discussing innovation in the treatment of aging and Rivka Zaibel from ADRES addressing regulatory aspects in drug development. Our Managing Partner and CEO of Peregrine’s incubator, Lior Shahory, shared valuable insights drawn from his extensive experience in healthcare ventures. He spoke about recognizing true medical needs, selecting the right focus areas, and how to evaluate when an idea has a strong potential to become a successful company. Lior also highlighted the key factors for building a successful medical enterprise, including how to effectively structure a financing plan, supported by case studies from his extensive career. Thank you, Yael Arusi and Benjamin Soffer, for inviting us and creating such an engaging platform for sharing ideas and insights!

DairyX is revolutionizing the foodtech industry! 🐄🧪 The company has achieved a major milestone in its mission to create authentic dairy protein without the cow. Using precision fermentation, DairyX has successfully developed a casein protein that can self-assemble into micelles, a crucial step in replicating the structure and function of cow's milk casein. From firm yogurt to stretchy cheese, DairyX's technology is poised to make a significant impact on the global food market. We are incredibly proud of the DairyX team and their dedication to innovation. Read more here : https://lnkd.in/dyGGt5vk #foodtech #innovation #vc #dairy #Israel

We’re excited to attend and speak at #LSIEurope24 next week in Sintra, Portugal! Join us for the panel on ‘Business Model Design in #DigitalHealth’ on September 18th at 3:15 PM. We’ll dive into creating, delivering, and capturing value while defending your business. Moderated by Joe Mullings of The Mullings Group, our own Boaz Lifcshitz will be joining Bryn Davies from Proximie and Addie H. Harris from HAVENTURE on the panel. We look forward to connecting with you all there!